product · release 2026-09-20
Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.
Printed organisms · observed
Quantities reflect printed organism rows.
| Printed name and notes | Normalized organism | Printed code | Printed deposit | Printed quantity | Flags |
|---|---|---|---|---|---|
| Lactobacillus gasseri KS-13 | Lactobacillus gasseri | KS-13 | not printed | not printed | T3; observed; quantity unavailable |
| Bifidobacterium bifidum G9-1 | Bifidobacterium bifidum | G9-1 | not printed | not printed | T3; observed; quantity unavailable |
| Bifidobacterium longum MM-2 | Bifidobacterium longum | MM-2 | not printed | not printed | T3; observed; quantity unavailable |
| Bifidobacterium animalis lactis | Bifidobacterium animalis | not printed | not printed | not printed | T4; observed; quantity unavailable |
| Bifidobacterium longum BB536 | Bifidobacterium longum | BB536 | not printed | not printed | T3; observed; quantity unavailable |
| Bifidobacterium breve M-16V | Bifidobacterium breve | M-16V | not printed | not printed | T3; observed; quantity unavailable |
| Bifidobacterium infantis M-63 | Bifidobacterium infantis | M-63 | not printed | not printed | T3; observed; quantity unavailable |
| Lactobacillus gasseri LAC-343 | Lactobacillus gasseri | LAC-343 | not printed | not printed | T3; observed; quantity unavailable |
| Lactobacillus rhamnosus LCS-742 | Lacticaseibacillus rhamnosus | LCS-742 | not printed | not printed | T3; observed; quantity unavailable |
Pack, dose and cost
Printed potency
No numeric quantity is printed on 9 organism rows of the latest observed label; potency basis The potency basis is not stated. 9 rows sit inside a proprietary blend, so their individual amounts are not disclosed.
Evidence behind the label
| Organism on this label | PubMed records indexed as human randomized controlled trials |
|---|---|
| Bifidobacterium animalis | 423 |
| Bifidobacterium bifidum | 136 |
| Bifidobacterium bifidum G9-1 | 3 |
| Bifidobacterium breve | 122 |
| Bifidobacterium breve M-16V | 22 |
| Bifidobacterium infantis | 58 |
| Bifidobacterium infantis M-63 | 4 |
| Bifidobacterium longum | 248 |
| Bifidobacterium longum BB536 | 38 |
| Bifidobacterium longum MM-2 | 2 |
| Lacticaseibacillus rhamnosus | 465 |
| Lacticaseibacillus rhamnosus LCS-742 | No query was run under the current method. |
| Lactobacillus gasseri | 43 |
| Lactobacillus gasseri LAC-343 | 0 |
Counts describe records matching each organism's published query, including trials of multi-ingredient products; they are not a count of trials of this product.
Context
This formulation scores above 11.9% of the 4,101 scored formulations in this release. The score is a preference-dependent summary of the axes, not a health claim.
| Other products carrying the same strain | Shared strain | Gut Index Score | Observed price |
|---|---|---|---|
| Kyo-Dophilus Kyo-Dophilus Pro+ Synbiotic Berry Smoothie | KS-13 | 65.69 | not observed |
| Thorne FloraMend Prime Probiotic | KS-13 | 65.47 | not observed |
| Bayer Phillips' Colon Health Daily Probiotic | KS-13 | 65.47 | $28.96 |
Axes 1–2
Evidence queries are incomplete. A2 uses the known matching records as a lower bound.
Scored using the available matching evidence. Identity: Only the species or an unresolved identity is available. Quantity disclosure: 0.0%. Potency: The potency basis is not stated.
Axes 3–4
Not a measurement product, so this axis does not apply.
No brand review panel is published in this release.
Price column
undefined: no permitted price observation in this release
Sensitivity
Preference interval 46.34–60.98; rank uncertainty 1959.95–2916.00; rank class 4.
Versions
Preference tool
The readout recomputes the arithmetic summary from the published component JSON. Axis fields remain primary.
Brand: Kyo-Dophilus — every published product of this brand, its potency basis and its observed reformulations.
Elsewhere in this release
Findings computed over the whole corpus: Potency basis census · Strain dose match · Supplier code network
Tools: Unit value calculator · DSLD product check
Citation
Ivitskiy, I. (2026). Kyo-Dophilus Multi 9 Probiotic. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/p/multi-9-probiotic/
The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.
Citable atoms
Kyo-Dophilus Multi 9 Probiotic: 8 of 9 observed organisms name a strain, and 0 print a deposit identifier. Latest observed label 219786. Window: NIH DSLD snapshot Sep 2026.
8 / 9 observed organisms · NIH DSLD snapshot Sep 2026 · product.organisms · checked 2026-09-20T00:00:00Z · snapshot b7633f732437Kyo-Dophilus Multi 9 Probiotic: 0 of 2 observed label snapshots state a potency basis; latest basis is not stated. Quantities reflect printed organism rows. Window: NIH DSLD snapshot Sep 2026.
0 / 2 observed label snapshots · NIH DSLD snapshot Sep 2026 · product.potency · checked 2026-09-20T00:00:00Z · snapshot b7633f732437Kyo-Dophilus Multi 9 Probiotic: 1 of 1 selected label snapshots have a numeric Gut Index Score; GIS 49.53 on the 100-point scale; rank class 4 of 4 across 3,279 scored formulations; nominal weights varied from 80.0% to 120.0% in preference sensitivity. Window: NIH DSLD snapshot Sep 2026.
1 / 1 selected label snapshots · NIH DSLD snapshot Sep 2026 · product.gis · checked 2026-09-20T00:00:00Z · snapshot b7633f732437Kyo-Dophilus Multi 9 Probiotic has 2 observed versions across 1 formulation groups; last recorded edge type: available at the same time. Window: NIH DSLD snapshot Sep 2026.
2 / 1 formulation groups · NIH DSLD snapshot Sep 2026 · product.versions · checked 2026-09-20T00:00:00Z · snapshot b7633f732437Kyo-Dophilus Multi 9 Probiotic: 0 of 2 observed versions have numeric prices; latest price No numeric price observation is available in this release.. Window: NIH DSLD snapshot Sep 2026.
0 / 2 observed label versions · NIH DSLD snapshot Sep 2026 · product.price · checked 2026-09-20T00:00:00Z · snapshot b7633f732437